Transthyretin Amyloidosis (ATTR) Market Report

China Transthyretin Amyloidosis (ATTR) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 14, 2023
  • PAGES：218
  • REPORT CODE：GMM1797264
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Transthyretin Amyloidosis (ATTR) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Arcturus Therapeutics

    • Ionis Pharmaceuticals

    • Proclara Bioscience

    • Corino Therapeutics

    By Type:

    • Hereditary ATTR (HATTR)

    • Wild-Type (WT) ATTR

    By Application:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Transthyretin Amyloidosis (ATTR) Market Overview 2018-2029

    • 1.1 China Transthyretin Amyloidosis (ATTR) Industry Development Overview

    • 1.2 China Transthyretin Amyloidosis (ATTR) Industry Development History

    • 1.3 China Transthyretin Amyloidosis (ATTR) Industry Market Size (2018-2029)

    • 1.4 China Transthyretin Amyloidosis (ATTR) Market Analysis by Type from Production Side

      • 1.4.1 China Transthyretin Amyloidosis (ATTR) Production Volume, Production Value and Growth Rate of Hereditary ATTR (HATTR) (2018-2029)

      • 1.4.2 China Transthyretin Amyloidosis (ATTR) Production Volume, Production Value and Growth Rate of Wild-Type (WT) ATTR (2018-2029)

    • 1.5 China Transthyretin Amyloidosis (ATTR) Market Analysis by Application from Consumption End

      • 1.5.1 China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

      • 1.5.3 China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • 1.6 China Transthyretin Amyloidosis (ATTR) Market Analysis by Region

      • 1.6.1 North China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Transthyretin Amyloidosis (ATTR) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Transthyretin Amyloidosis (ATTR) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Transthyretin Amyloidosis (ATTR) Market Status and Competition Analysis in 2023

      • 2.2.3 China Transthyretin Amyloidosis (ATTR) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Transthyretin Amyloidosis (ATTR) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Transthyretin Amyloidosis (ATTR) Industry Development

    Chapter 3 Transthyretin Amyloidosis (ATTR)Industry Chain Analysis

    • 3.1 Transthyretin Amyloidosis (ATTR) Industry Chain

    • 3.2 Transthyretin Amyloidosis (ATTR) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Transthyretin Amyloidosis (ATTR) Market

    • 3.3 Transthyretin Amyloidosis (ATTR) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Transthyretin Amyloidosis (ATTR) Market

    Chapter 4 China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 4.1 China Transthyretin Amyloidosis (ATTR) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Transthyretin Amyloidosis (ATTR) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Transthyretin Amyloidosis (ATTR) Production Volume and Growth Rate, by Type

      • 4.5.1 China Transthyretin Amyloidosis (ATTR) Production Volume and Growth Rate of Hereditary ATTR (HATTR)

      • 4.5.2 China Transthyretin Amyloidosis (ATTR) Production Volume and Growth Rate of Wild-Type (WT) ATTR

    Chapter 5 China Transthyretin Amyloidosis (ATTR) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Transthyretin Amyloidosis (ATTR) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate, by Application

      • 5.5.1 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hospitals

      • 5.5.2 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Ambulatory Surgical Centers

      • 5.5.3 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Diagnostic Centers

    Chapter 6 China Transthyretin Amyloidosis (ATTR) Market, by Region

    • 6.1 China Transthyretin Amyloidosis (ATTR) Production Volume and Production Value, by Region

    • 6.2 China Transthyretin Amyloidosis (ATTR) Sales Volume and Sales Value, by Region

    Chapter 7 North China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 7.1 North China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 7.2 North China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 8 Central China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 8.1 Central China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 8.2 Central China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 9 South China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 9.1 South China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 9.2 South China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 10 East China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 10.1 East China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 10.2 East China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 11 Northeast China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 11.1 Northeast China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 11.2 Northeast China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 12 Southwest China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 12.1 Southwest China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 12.2 Southwest China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 13 Northwest China Transthyretin Amyloidosis (ATTR) Market Analysis

    • 13.1 Northwest China Transthyretin Amyloidosis (ATTR) Market, by Type

    • 13.2 Northwest China Transthyretin Amyloidosis (ATTR) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Transthyretin Amyloidosis (ATTR) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Arcturus Therapeutics

        • 14.2.1 Arcturus Therapeutics Company Profile

        • 14.2.2 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Ionis Pharmaceuticals

        • 14.3.1 Ionis Pharmaceuticals Company Profile

        • 14.3.2 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Proclara Bioscience

        • 14.4.1 Proclara Bioscience Company Profile

        • 14.4.2 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Corino Therapeutics

        • 14.5.1 Corino Therapeutics Company Profile

        • 14.5.2 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Market Performance

        • 14.5.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Transthyretin Amyloidosis (ATTR) Industry Research Conclusions

    • 15.2 Transthyretin Amyloidosis (ATTR) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Transthyretin Amyloidosis (ATTR) Industry Market Size (2018-2029)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Volume, Production Value and Growth Rate of Hereditary ATTR (HATTR) (2018-2029)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Volume, Production Value and Growth Rate of Wild-Type (WT) ATTR (2018-2029)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • Figure North China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure Central China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure South China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure East China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate from 2018-2029

    • Figure Transthyretin Amyloidosis (ATTR) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Transthyretin Amyloidosis (ATTR) Market Share by Type in 2018

    • Figure China Transthyretin Amyloidosis (ATTR) Market Share by Type in 2023

    • Figure China Transthyretin Amyloidosis (ATTR) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Volume and Growth Rate of Hereditary ATTR (HATTR) (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Volume and Growth Rate of Wild-Type (WT) ATTR (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Market Share by Application in 2018

    • Figure China Transthyretin Amyloidosis (ATTR) Market Share by Application in 2023

    • Figure China Transthyretin Amyloidosis (ATTR) Total Market Size and Growth Rate from Consumption End

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Diagnostic Centers (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Production Volume by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Production Volume Share by Region (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Volume Share by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Production Value by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Production Value Share by Region (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Production Value Share by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Volume by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Region (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Value by Region (2018-2023)

    • Table China Transthyretin Amyloidosis (ATTR) Sales Value Share by Region (2018-2023)

    • Figure China Transthyretin Amyloidosis (ATTR) Sales Value Share by Region (2018-2023)

    • Table North China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table North China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure North China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table North China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table North China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure North China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table Central China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table Central China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure Central China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table Central China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table Central China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure Central China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table South China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table South China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure South China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table South China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table South China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure South China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table East China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table East China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure East China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table East China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table East China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure East China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Production Volume by Type (2018-2023)

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Production Volume Share by Type (2018-2023)

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Sales Volume by Application (2018-2023)

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Transthyretin Amyloidosis (ATTR) Revenue, Price and Gross (2018-2023)

    • Table Arcturus Therapeutics Company Profile

    • Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Price and Gross (2018-2023)

    • Table Ionis Pharmaceuticals Company Profile

    • Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Price and Gross (2018-2023)

    • Table Proclara Bioscience Company Profile

    • Table Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue, Price and Gross (2018-2023)

    • Table Corino Therapeutics Company Profile

    • Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US